Heiner Wedemeyer
Hannover Medical School, Department of Gastroenterology, Hepatology and Endocrinology · Dept. of Gastroenterology, Hepatology and Endocrinology Medizinische Hochschule Hannover · Hannover Medical School, Department of Gastroenterology, Hepatology and Endocrinology, Carl-Neuberg-Str. 1, 30625 Hannover, Germany
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Heiner Wedemeyer as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:02 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05345990 · Treatment of Patients With Chronic Hepatitis B With Hepatitis B ImmunoglobulinsHannover Medical School · terminated · Chronic Hepatitis B · principal investigator
- Ph2NCT03546621 · A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis DHepatera Ltd. · completed · Chronic Hepatitis D Infection With Hepatitis B · principal investigator
- Ph4NCT03003338 · MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSVHannover Medical School · terminated · Hepatitis C, Chronic · principal investigator
- Ph2NCT02527707 · Titrating-Dose of Lonafarnib in Combination With RitonavirEIT Pharma, Inc. · completed · Chronic Delta Hepatitis · principal investigator
- Ph3NCT01046799 · Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With EntecavirHepNet Study House, German Liverfoundation · completed · Liver Transplantation, Hepatitis B, Liver Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:02 UTC. The ranking covers the 200 most relevant of 94 PubMed records, and a shared surname and initials can bring in a namesake. All 94 on PubMed
- ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis.N Engl J Med · 2014721 citationsRCR 25.8
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.J Hepatol · 2017662 citationsRCR 22.0
- Treatment of acute hepatitis C with interferon alfa-2b.N Engl J Med · 2001577 citationsRCR 14.5
- Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.N Engl J Med · 2014465 citationsRCR 16.5
- Peginterferon plus adefovir versus either drug alone for hepatitis delta.N Engl J Med · 2011376 citationsRCR 10.8
- Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.N Engl J Med · 2018337 citationsRCR 15.3
- Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.J Hepatol · 2016317 citationsRCR 11.3
- Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.Gastroenterology · 2004242 citationsRCR 5.5
- A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.N Engl J Med · 2023213 citationsRCR 22.0
- 182 citationsRCR 6.2